Investigation of the role of the p38 MAPK α and δ isoforms in nonresponse to tumour necrosis factor blockade in the synovium of rheumatoid arthritis patients

被引:0
|
作者
LR Coulthard
LD Church
RJ Mathews
S Churchman
L Dickie
M Buch
R Reece
A English
AW Morgan
S Gay
P Emery
MF McDermott
机构
[1] St James's University Hospital,Leeds Institute of Molecular Medicine
[2] University Hospital,Department of Rheumatology
关键词
Rheumatoid Arthritis; Infliximab; Rheumatoid Arthritis Patient; Rheumatoid Arthritis Synovium; ACR20 Response;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Investigation of the role of the p38 MAPK α and δ isoforms in nonresponse to tumour necrosis factor blockade in the synovium of rheumatoid arthritis patients
    Coulthard, L. R.
    Church, L. D.
    Mathews, R. J.
    Churchman, S.
    Dickie, L.
    Buch, M.
    Reece, R.
    English, A.
    Morgan, A. W.
    Gay, S.
    Emery, P.
    McDermott, M. F.
    ARTHRITIS RESEARCH & THERAPY, 2007, 9 (Suppl 3)
  • [2] Investigation of the role of p38 MAPK isoforms in the rheumatoid synovium
    Coulthard, L. R.
    English, A.
    Reece, R.
    Church, L. D.
    Buch, M.
    Mathews, R. J.
    Churchman, S. M.
    Gay, S.
    Emery, P.
    McDermott, M. F.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : A48 - A48
  • [3] Investigation of the role of P38 mapk alpha and delta isoforms in non-response to TNF blockade in the synovium of rheumatoid arthritis patients
    Coulthard, L. R.
    Church, L. D.
    Mathews, R. J.
    Churchman, S.
    Dickie, L.
    Buch, M.
    Reece, R.
    English, A.
    Morgan, A. W.
    Gay, S.
    Emery, P.
    McDermott, M. F.
    RHEUMATOLOGY, 2007, 46 : I44 - I44
  • [4] Differential tissue expression and activation of p38 MAPK α, β, γ, and δ isoforms in rheumatoid arthritis
    Korb, Adelheid
    Tohidast-Akrad, Makiyeh
    Cetin, Erdal
    Axmann, Roland
    Smolen, Josef
    Schett, Georg
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : 2745 - 2756
  • [5] Tumour necrosis factor blockade in rheumatoid arthritis
    Breedveld, FC
    CLINICAL MEDICINE, 2001, 1 (02) : 107 - 109
  • [6] Upregulation of p38αMAPK activation in patients with rheumatoid arthritis
    Chikanza, I. C.
    Kozaci, D. L.
    RHEUMATOLOGY, 2006, 45 : I32 - I32
  • [7] p38 MAPK inhibitor for the treatment of rheumatoid arthritis
    Hart, Michelle
    Bryant, Shaughn
    Hyland, Deborah
    Goudreau, Regina
    Waegell, Wendy
    Murtaza, Anwar
    Olson, Lisa
    Calderwood, David
    Schopf, Lisa
    INFLAMMATION RESEARCH, 2008, 57 : S97 - S97
  • [8] Is there a critical role for MAPK p38 in disease development and chronicity of rheumatoid arthritis?
    Li, C
    Owen, S
    Green, P
    Amjadi, P
    Beech, J
    Brennan, FM
    IMMUNOLOGY, 2005, 116 : 88 - 88
  • [9] Perturbations of p38αMAPK activation in patients with corticosteroid resistant rheumatoid arthritis
    Chikanza, I. C.
    Kozaci, D. L.
    RHEUMATOLOGY, 2006, 45 : I58 - I58
  • [10] Angiopoietin-1 is expressed in the synovium of patients with rheumatoid arthritis and is induced by tumour necrosis factor α
    Gravallese, EM
    Pettit, AR
    Lee, R
    Madore, R
    Manning, C
    Tsay, A
    Gaspar, J
    Goldring, MB
    Goldring, SR
    Oettgen, P
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (02) : 100 - 107